Larvol Delta - Study-of-Class-I-HDAC1-2-and-3-Inhibitors-Designed-by-Bioisosteric-Replacement-of-Zinc-Binding-Groups-and-Caps-of-Traditional-Pan-Inhibitors-An-In-Silico-Approach

Zolinza (vorinostat) - Merck (MSD)

Duvyzat (givinostat) - Italfarmaco

Beleodaq (belinostat) - Aurobindo, Assertio

http://www.ncbi.nlm.nih.gov/pubmed/42370516

Ercan Bursal; Hayiru Mohammed; Manikanta Murahari; Simon Mugisa

Jun 30, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next